+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transcutaneous Electrical Nerve Stimulation Market Size, Share & Trends Analysis by Product Type (Portable, Table Top), by Application (Chronic Pain, Acute Pain), by End-use (Hospitals, Physiotherapy Clinics), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 110 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5595835
The global transcutaneous electrical nerve stimulation market is anticipated to reach USD 419.48 million by 2030, and is expected to expand at a CAGR of 3.84% from 2022 to 2030. Rising cases of chronic pain, sports injuries, along with an increasing geriatric population base are some of the major factors driving transcutaneous electrical nerve stimulation market growth. For instance, as per a CDC report, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had high impact chronic pain (limited work activities) in the U.S.



Moreover, the growing preference for TENS among physiotherapists is further aiding in the market growth. Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and at-home settings as they consume less time and are more effective. This is expected to drive the transcutaneous electrical nerve stimulation growth over the forecast period.

The outbreak of COVID-19 in the year 2020 has moderately hampered the market expansion owing to the issues such as the disruption of the medical supply chain, delayed production, and a restricted workforce. However, the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions across the borders, are expected to have a positive impact on the transcutaneous electrical nerve stimulation market in the coming years.

Transcutaneous Electrical Nerve Simulation Market Report Highlights

  • Based on product type, the portable segment dominated the market with a revenue share of 71.70% in 2021 and is anticipated to witness the highest CAGR of 4.0% during the forecast period. Portable TENS would decrease the number of doctor visits for patients, therefore are anticipated to support market growth over the forecast period.
  • Based on application, the chronic pain segment is likely to witness the fastest growth in the forecast period, owing to the growing prevalence of chronic pain, especially amongst senior citizens.
  • Based on end-use, physiotherapy clinics dominated the market. The growing preference of physiotherapists toward electrotherapy as compared to manual techniques is a major factor driving the growth of this segment.
  • On the other hand, the home healthcare segment is anticipated to witness the fastest growth of a CAGR of 4.9% over the forecast period.
  • North America dominated the market with the highest revenue share of 43.91% in 2021 owing to the presence of key participants, and the high purchasing power of consumers.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Transcutaneous Electrical Nerve Stimulation Market

What is the estimated value of the Global Transcutaneous Electrical Nerve Stimulation Market?

The Global Transcutaneous Electrical Nerve Stimulation Market was estimated to be valued at $310.24 Million in 2022.

What is the growth rate of the Global Transcutaneous Electrical Nerve Stimulation Market?

The growth rate of the Global Transcutaneous Electrical Nerve Stimulation Market is 3.8%, with an estimated value of $419.48 Million by 2030.

What is the forecasted size of the Global Transcutaneous Electrical Nerve Stimulation Market?

The Global Transcutaneous Electrical Nerve Stimulation Market is estimated to be worth $419.48 Million by 2030.

Who are the key companies in the Global Transcutaneous Electrical Nerve Stimulation Market?

Key companies in the Global Transcutaneous Electrical Nerve Stimulation Market include Omron Corporation, Zynex Medical, Neurometrix, Inc., Ems Physio Ltd., Biomedical Life Systems, Djo Global, Inc. and Globus.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Product Type
1.1.2 Application
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 PRIMARY Research
1.3.5 Details OF Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Vplume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Transcutaneous Electrical Nerve Stimulation (TENS) Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Rising Cases Of Chronic and Acute Pain
3.5.1.2 Ineffectiveness Of Oral Drugs and Low Preference For Surgical Intervention
3.5.1.3 Rising Geriatric Population
3.5.1.4 Rising Demand For Reduced Hospital Stay
3.5.1.5 Increasing Number Of Surgeries
3.5.1.6 Rising Cases Of Anterior Cruciate Ligament (Acl) Tear, Hip Flexor Strain, and Hamstring Strain Among Sports Players
3.5.2 Market Restraints Analysis
3.5.2.1 Adverse Effects Associated With Devices
3.5.2.2 Increased Cost Of Nerve Stimulation Therapy
3.6 Transcutaneous Electrical Nerve Stimulation: Market Analysis Tools
3.6.1 Industry Analysis-PORTER’S
3.6.2 SWOT Analysis, by PEST
3.7 Impact Of COVID-19 On Market
Chapter 4 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Segment Analysis, by Product Type, 2017-2030 (USD Million)
4.1 Definition and Scope
4.2 Product Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Transcutaneous Electrical Nerve Stimulation Market, by Product Type Type, 2017 To 2030
4.5 Market Size & Forecasts and Trend Analysis, 2017 To 2030
4.5.1 PorTables Tens
4.5.1.1 PorTable Tens Market, 2017-2030 (USD Million)
4.5.2 Table Top Tens
4.5.2.1 Table Top Tens Market, 2017-2030 (USD Million)
Chapter 5 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Segment Analysis, by Application, 2017-2030 (USD Million)
5.1 Definition and Scope
5.2 Application Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Transcutaneous Electrical Nerve Stimulation Market, by Application, 2017 To 2030
5.5 Market Size & Forecasts and Trend Analysis, 2017 To 2030
5.5.1 Chronic Pain
5.5.1.1 Chronic Pain Market, 2017-2030 (USD Million)
5.5.1.1.1 Arthritis Market, 2017-2030 (USD Million)
5.5.1.1.2 Back & Neck Pain Market, 2017-2030 (USD Million)
5.5.1.1.3 Fibromyalgia Market, 2017-2030 (USD Million)
5.5.1.1.4 Neuropathic Pain Market, 2017-2030 (USD Million)
5.5.1.1.5 Others Market, 2017-2030 (USD Million)
5.5.2 Acute Pain
5.5.2.1 Acute Pain Market, 2017-2030 (USD Million)
5.5.2.1.1 Sports Injuries Market, 2017-2030 (USD Million)
5.5.2.1.2 Postoperative Pain Market, 2017-2030 (USD Million)
5.5.2.1.3 Labor Pain Market, 2017-2030 (USD Million)
5.5.2.1.4 Menstrual Pain Market, 2017-2030 (USD Million)
Chapter 6 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Segment Analysis, by End-Use, 2017-2030 (USD Million)
6.1 Definition and Scope
6.2 End-Use Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Transcutaneous Electrical Nerve Stimulation Market, by End-Use, 2017 To 2030
6.5 Market Size & Forecasts and Trend Analysis, 2017 To 2030
6.5.1 Hospitals
6.5.1.1 Hospitals Market, 2017-2030 (USD Million)
6.5.2 Physiotherapy Clinics
6.5.2.1 Physiotherapy Clinics Market, 2017-2030 (USD Million)
6.5.3 Rehabilitation Centers
6.5.3.1 Rehabilitation Centers Market, 2017-2030 (USD Million)
6.5.4 Home Care
6.5.4.1 Home Care Market, 2017-2030 (USD Million)
6.5.5 Others
6.5.5.1 Others Market, 2017-2030 (USD Million)
Chapter 7 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Regional Market Analysis, by Product Type, by Application, by End-Use 2017-2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Market Size, & Forecasts, and Trend Analysis, 2020 To 2028
7.6 North America
7.6.1 North America Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.6.2 U.S.
7.6.2.1 U.S. Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.6.3 Canada
7.6.3.1 Canada Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.7 Europe
7.7.1 Europe Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.7.2 U.K.
7.7.2.1 U.K. Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.7.3 Germany
7.7.3.1 Germany Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.7.4 France
7.7.4.1 France Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.7.5 Italy
7.7.5.1 Italy Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.7.6 Spain
7.7.6.1 Spain Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.8 Asia Pacific
7.8.1 Asia Pacific Transcutaneous Electrical Nerve StimulationMarket, 2017-2030 (USD Million)
7.8.2 Japan
7.8.2.1 Japan Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.8.3 China
7.8.3.1 China (Mainland) Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.8.4 India
7.8.4.1 India Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.8.5 South Korea
7.8.5.1 South Korea Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.8.6 Australia
7.8.6.1 Australia Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.9 Latin America
7.9.1 Latin America Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.9.2 Brazil
7.9.2.1 Brazil Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.9.3 Mexico
7.9.3.1 Mexico Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.9.4 Argentina
7.9.4.1 Argentina Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.9.5 Colombia
7.9.5.1 Colombia Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.10 MEA
7.10.1 MEA Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.10.2 South Africa
7.10.2.1 South Africa Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.10.3 Saudi Arabia
7.10.3.1 Saudi Arabia Transcutaneous Electrical Nerve Stimulation Market, 2017-2030 (USD Million)
7.10.4 Saudi Arabia
7.10.4.1 UAE Market, 2017-2030 (USD Million)
Chapter 8 Transcutaneous Electrical Nerve Stimulation (TENS) Market-Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Company Profiles
8.3.1 OMRON CORPORATION
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 ZYNEX MEDICAL
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 NEUROMETRIX, INC.
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 EMS PHYSIO LTD.
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 BIOMEDICAL LIFE SYSTEMS
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 DJO GLOBAL, INC.
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 GLOBUS
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives

Companies Mentioned

  • Omron Corporation
  • Zynex Medical
  • Neurometrix, Inc.
  • Ems Physio Ltd.
  • Biomedical Life Systems
  • Djo Global, Inc.
  • Globus

Methodology

Loading
LOADING...